Lumida
/SLQT
⌘K
SelectQuote Inc

SelectQuote Inc

SLQT
$0.50USD↓-2.84%-0.01 today

MARKET CAP

88.3M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$0 – $1

52W RANGE

$0
$2

AI Summary

Stalk
StalkMedium

SLQT's primary Bullish Pivot Point pattern signals structural repair and a shift toward upward mean reversion after a prolonged downtrend. Despite a medium-term bullish bias, the stock is extended above flattening short-term EMAs with muted volume, offering no clear entry edge. We will stalk pullbacks into the rising 9EMA/20EMA support zone around $0.75–$0.78 to balance early reversal signals against the longer-term downtrend.

  • ↑Q3 revenue reached $431M (+6% YoY), driven by senior and healthcare segments.
  • ↑Adjusted EBITDA rose 18% YoY to $45M, reflecting improved operational efficiency.
  • ↓P/E ratio of ~59.7× implies overvaluation if growth decelerates.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

SelectQuote, Inc. (NYSE: SLQT) operates a technology-driven insurance brokerage, primarily focusing on Medicare Advantage, life insurance, and healthcare services. The company leverages its ability to connect consumers with tailored insurance solutions through its unique agent-led model, establishing itself as a critical player in the senior insurance market. SelectQuote is part of the broader trend in healthcare services, aiming to improve patient engagement and care accessibility, which positions it well within the evolving landscape of the insurance industry.

Bull says

  • ↑Q3 revenue reached $431M (+6% YoY), driven by senior and healthcare segments.
  • ↑Adjusted EBITDA rose 18% YoY to $45M, reflecting improved operational efficiency.
  • ↑Healthcare services revenue jumped 55% YoY; SelectRx membership exceeded 2M.
  • ↑Operating cash flow guidance of $25–35M for fiscal 2026 underscores strong cash generation.
  • ↑Technology-driven agent model offers scalable edge against major insurers.
  • ↑Strong profitability and positive analyst revisions support growth outlook.

Bear says

  • ↓P/E ratio of ~59.7× implies overvaluation if growth decelerates.
  • ↓Negative dividend yield suggests limited income for shareholders.
  • ↓Medicare Advantage regulatory changes may disrupt revenue streams.
  • ↓High stock volatility and low institutional interest raise liquidity concerns.
  • ↓Intense competition could compress margins and pressure agent performance.
  • ↓Reliance on agent-led model poses execution risk amid market shifts.

Investment themes with SLQT

L&H Insurance↑ +0.38%

MFC · PUK · SLF

Earnings Call · Q4 2025 · Mgmt. Guidance

Updated 08-26-2026bullish

Transcript signals

Bull points

  • SelectQuote grew revenue 15.5% to $1.53 billion. Our full-year adjusted EBITDA totaled $126 million, which grew 8% compared to a year ago.
  • we drove 12 million of adjusted EBITDA in healthcare services, which represents a margin of 5.5%, which on a year-over-year basis compares to a quarter where we effectively broke even for this segment.
  • We expect revenue in the range of $1.65 to $1.75 billion, which represents year-over-year growth of approximately 11% at the midpoints.
Read full transcript analysis ›